Results 171 to 180 of about 123,648 (399)
Movement Disorders Clinical Practice, EarlyView.Abstract Background Anticholinergic medications and botulinum neurotoxin injections are established treatments for dystonia, yet they carry potential side effects and practical challenges. Deep brain stimulation (DBS) is offered in case of poor response to these approaches.
Marcela A. Montiel +5 more
wiley +1 more source
Segmental Reflex, Long Latency Reflex, and Mixed Nerve Silent Period in Dystonia [PDF]
, 2023 Ayşegül Gündüz +3 more
openalex +1 more source
Critical developmental periods of vulnerability in dystonia
DystoniaDystonia is a heterogenous movement disorder characterised by involuntary muscle contractions, leading to abnormal postures and movements. Despite being the third most common movement disorder, the pathophysiological mechanisms causing dystonia are ...
Simon A. Lowe
doaj +1 more source
Huntington's Disease and Huntington's Disease‐like 2 (HDL2) in Martinique
Movement Disorders Clinical Practice, EarlyView.ABSTRACT Background Huntington's Disease‐like 2 (HDL2), caused by a CAG repeat expansion in JPH3, closely resembles HD. All reported HDL2 patients to date have some African ancestry. While both disorders exist in the Caribbean, their relative frequency and clinical characteristics remain largely unknown.
Ignacio Antolin‐Sanfeliz +8 more
wiley +1 more source
Challenges in deep brain stimulation for DYT-11: a single center troubleshooting experience
DystoniaIntroductionDYT-11 is a form of myoclonus dystonia (MD) characterized by involuntary muscle jerks and abnormal postures attributable to a variant in the epsilon sarcoglycan (SGCE) gene.
Matthew Aaron Remz +8 more
doaj +1 more source
A narrative review: clinical trials in therapeutic interventions for dystonia (2020 - 2025)
DystoniaDystonia is a disabling movement disorder affecting millions of people. Approach to managing this disorder in clinical practice include oral and intrathecal medication therapy, botulinum toxin injections, deep brain stimulation, rehabilitative regimens ...
Ann Ly +9 more
doaj +1 more source
Dopa-responsive dystonia and hyperprolactinaemia : a novel association in two sisters [PDF]
, 2007 Dopa-Responsive Dystonia (DRD) is a rare hereditary condition of childhood-onset dystonia which responds dramatically to treatment with levodopa. It was first described in 1971 as a "hereditary progressive basal ganglia disease with marked diurnal ...
Cachia, Mario J., Galea, Janabel
core
A New Phenotype–Genotype Correlation for FIG4 and Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.
Iro Boura +4 more
wiley +1 more source